Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor

Cancer Research

Volumn 69, Issue 23, 2009, Pages 8877-8885

  Kuo, Ping Chang ^a   Tsao, Yeou Ping ^b   Chang, Hung Wei ^a   Chen, Po Han ^a   Huang, Chu Wei ^a   Lin, Shinn Tsuen ^a   Weng, Yu Tzu ^a   Tsai, Tzung Chieh ^d   Shieh, Sheau Yann ^c   Chen, Show Li ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER AMPLIFIED SEQUENCE 2 PROTEIN; DNA; DOXORUBICIN; NUCLEAR PROTEIN; PROTEIN P53; SERINE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

APOPTOSIS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL NUCLEUS; DNA DAMAGE; HUMANS; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71549159140     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2023     Document Type: Article

References (49)

1. Maass N, Rosel F, SchemC, Hitomi J, Jonat W, Nagasaki K. Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer. Cancer Lett 2002;185:219-223 (Pubitemid 34886536)
2. Nagasaki K, Maass N, Manabe T, et al. Identification of a novel gene, DAM1, amplified at chromosome 1p13.3-21 region in human breast cancer cell lines. Cancer Lett 1999;140:219-226 (Pubitemid 29251334)
3. Neubauer G, King A, Rappsilber J, et al. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet 1998;20:46-50. (Pubitemid 28410342)
4. Qi C, Zhu YT, Chang J, Yeldandi AV, Rao MS, Zhu YJ. Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2. Biochem Biophys Res Commun 2005;328:393-398 (Pubitemid 40208324)
5. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-412 (Pubitemid 351574202)
6. Fuster JJ, Sanz-Gonzalez SM, Moll UM, Andres V. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med 2007;13:192-199 (Pubitemid 46687126)
7. Shangary S, Wang S. Targeting the MDM2-53 interaction for cancer therapy. Clin Cancer Res 2008;14:5318-5324
8. Colaluca IN, Tosoni D, Nuciforo P, et al. NUMB controls p53 tumour suppressor activity. Nature 2008;451:76-80.
9. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001;8:781-794 (Pubitemid 33030212)
10. Slee EA, O'Connor DJ, Lu X. To die or not to die: how does p53 decide? Oncogene 2004;23:2809-2818
11. Chen PH, Tsao YP, Wang CC, Chen SL. Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability. Nucleic Acids Res 2008;36:51-66.
12. Tsai TC, Lee YL, Hsiao WC, Tsao YP, Chen SL. NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors. J Biol Chem 2005;280:20000-20009
13. Klein C, Vassilev LT. Targeting the p53-2 interaction to treat cancer. Br J Cancer 2004;91:1415-1419 (Pubitemid 39486340)
14. Vousden KH. Outcomes of p53 activation-spoilt for choice. J Cell Sci 2006;119:5015-5020
15. O'Callaghan-Sunol C, Gabai VL, Sherman MY. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 2007;67:11779-11788
16. Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL. Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol 1999;73:4983-4990 (Pubitemid 29246759)
17. Resnick-Silverman L, Manfredi JJ. Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy. J Cell Biochem2006;99:679-689
18. Grigoryan G, Keating AE. Structural specificity in coiled-coil interactions. Curr Opin Struct Biol 2008;18:477-483
19. Liu J, Zheng Q, Deng Y, Cheng CS, Kallenbach NR, Lu M. A seven-helix coiled coil. Proc Natl Acad Sci U S A 2006;103:15457-15462
20. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-378 (Pubitemid 39265678)
21. Lu X. p53: a heavily dictated dictator of life and death. Curr Opin Genet Dev 2005;15:27-33.
22. Wolff S, Erster S, Palacios G, Moll UM. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 2008;18:733-744 (Pubitemid 351948223)
23. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 2007;26:923-934 (Pubitemid 46321418)
24. Moll UM, Wolff S, Speidel D, Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 2005;17:631-636
25. Kitagawa M, Lee SH, McCormick F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 2008;29:217-231 (Pubitemid 351172826)
26. Olsson A, Manzl C, Strasser A, Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 2007;14:1561-1575
27. Pluquet O, Qu LK, Baltzis D, Koromilas AE. Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3β. Mol Cell Biol 2005;25:9392-9405 (Pubitemid 41507840)
28. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007;130:597-600.
29. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PR. Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells. Br J Cancer 2002;87:909-917 (Pubitemid 35252969)
30. Cronauer MV, Schulz WA, Burchardt T, Ackermann R, Burchardt M. Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines. Oncogene 2004;23:3541-3549 (Pubitemid 38658420)
31. Huang J, Sengupta R, Espejo AB, et al. p53 is regulated by the lysine demethylase LSD1. Nature 2007;449:105-108 (Pubitemid 47373772)
32. Wang W, El-Deiry WS. Restoration of p53 to limit tumor growth. Curr Opin Oncol 2008;20:90-96 (Pubitemid 350190987)
33. Yang Y, Li CC, Weissman AM. Regulating the p53 system through ubiquitination. Oncogene 2004;23:2096-2106 (Pubitemid 38496739)
34. Momand J, Jung D, Wilczynski S, Niland J. The MDM2 gene amplification database. Nucleic Acids Res 1998;26:3453-3459
35. Levav-Cohen Y, Haupt S, Haupt Y. Mdm2 in growth signaling and cancer. Growth Factors 2005;23:183-192
36. Bergam aschi D, Sam uels Y, Zhong S, Lu X. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation. Oncogene 2005;24:3836-3841
37. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793-805.
38. Braithwaite AW, Del Sal G, Lu X. Some p53-binding proteins that can function as arbiters of life and death. Cell Death Differ 2006;13:984-993 (Pubitemid 43753489)
39. D'Souza S, Xin H, Walter S, Choubey D. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J Biol Chem 2001;276:298-305. (Pubitemid 32050320)
40. Li L, Deng B, Xing G, et al. PACT is a negative regulator of p53 and essential for cell growth and embryonic development. Proc Natl Acad Sci U S A 2007;104:7951-7956 (Pubitemid 47185857)
41. Wang Z, Fukuda S, Pelus LM. Survivin regulates the p53 tumor suppressor gene family. Oncogene 2004;23:8146-8153 (Pubitemid 39531855)
42. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350
43. Katayama H, Sasai K, Kawai H, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004;36:55-62. (Pubitemid 38056208)
44. Beck BD, Park SJ, Lee YJ, Roman Y, Hromas RA, Lee SH. Human Pso4 is a metnase (SETMAR)-binding partner that regulates metnase function in DNA repair. J Biol Chem 2008;283:9023-9030
45. Kleinridders A, Pogoda HM, Irlenbusch S, et al. PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis. Mol Cell Biol 2009;29:3173-3185
46. 2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev 2005;19:2705-2714
47. Mahajan KN, Mitchell BS. Role of human Pso4 in mammalian DNA repair and association with terminal deoxynucleotidyl transferase. Proc Natl Acad Sci U S A 2003;100:10746-10751
48. Russell CS, Ben-Yehuda S, Dix I, Kupiec M, Beggs JD. Functional analyses of interacting factors involved in both pre-mRNA splicing and cell cycle progression in Saccharomyces cerevisiae. RNA 2000;6:1565-1572 (Pubitemid 30842476)
49. Zhang N, Kaur R, Lu X, Shen X, Li L, Legerski RJ. The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand crosslinks. J Biol Chem2005;280:40559-40567